These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11015010)

  • 1. r-HuEPO resistance and dialysate chloramine contamination in patients on hemodialysis.
    Pérez-García R; Verde E; Sanz A; Valderrábano F
    Nephron; 2000 Oct; 86(2):222-3. PubMed ID: 11015010
    [No Abstract]   [Full Text] [Related]  

  • 2. Warning: an anemia outbreak due to chloramine exposure in a clean hemodialysis unit--an issue to be revisited.
    de Oliveira RM; de los Santos CA; Antonello I; d'Avila D
    Ren Fail; 2009; 31(1):81-3. PubMed ID: 19142815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloramine-induced haemolysis presenting as erythropoietin resistance.
    Fluck S; McKane W; Cairns T; Fairchild V; Lawrence A; Lee J; Murray D; Polpitiye M; Palmer A; Taube D
    Nephrol Dial Transplant; 1999 Jul; 14(7):1687-91. PubMed ID: 10435877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin resistance due to dialysate chloramine: the two-way traffic of solutes in haemodialysis.
    Richardson D; Bartlett C; Goutcher E; Jones CH; Davison AM; Will EJ
    Nephrol Dial Transplant; 1999 Nov; 14(11):2625-7. PubMed ID: 10534502
    [No Abstract]   [Full Text] [Related]  

  • 5. Illness in hemodialysis patients after exposure to chloramine contaminated dialysate.
    Tipple MA; Shusterman N; Bland LA; McCarthy MA; Favero MS; Arduino MJ; Reid MH; Jarvis WR
    ASAIO Trans; 1991; 37(4):588-91. PubMed ID: 1768494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloramine-induced hemolysis associated with neurological symptoms in a home hemodialysis patient.
    Kitching AR; Ritchie D; Wong JK; May A; Hatfield PJ
    Clin Nephrol; 2001 Mar; 55(3):259-60. PubMed ID: 11316249
    [No Abstract]   [Full Text] [Related]  

  • 7. When pure is not so pure: chloramine-related hemolytic anemia in home hemodialysis patients.
    Junglee NA; Rahman SU; Wild M; Wilms A; Hirst S; Jibani M; Seale JR
    Hemodial Int; 2010 Jul; 14(3):327-32. PubMed ID: 20618875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorinated urban water: a cause of dialysis-induced hemolytic anemia.
    Eaton JW; Kolpin CF; Swofford HS; Kjellstrand CM; Jacob HS
    Science; 1973 Aug; 181(4098):463-4. PubMed ID: 4718115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA safety alert: chloramine contamination of hemodialysis water supplies.
    Villforth JC
    Am J Kidney Dis; 1988 May; 11(5):447. PubMed ID: 3369445
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of erythropoietin in emergencies: massive intoxication by chloramines.
    Lorenzo I; Medina M; Calderon P; Castro S; Lazaro R
    EDTNA ERCA J; 1996; 22(1):31-3. PubMed ID: 10723309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to manage the chloramine problem.
    Petersen MD; Filkins C
    Nephrol News Issues; 1989 Dec; 3(12):28, 30. PubMed ID: 2608141
    [No Abstract]   [Full Text] [Related]  

  • 12. Chloramines, an aggravating factor in the anemia of patients on regular dialysis treatment.
    Botella J; Traver JA; Sanz-Guajardo D; Torres MT; Sanjuan I; Zabala P
    Proc Eur Dial Transplant Assoc; 1977; 14():192-9. PubMed ID: 600956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ascorbic acid to remove chloramine from dialysate water.
    Wiseman KC
    ANNA J; 1997 Feb; 24(1):67-8. PubMed ID: 9146126
    [No Abstract]   [Full Text] [Related]  

  • 14. Chloramine removal from water used in hemodialysis.
    Ward DM
    Adv Ren Replace Ther; 1996 Oct; 3(4):337-47. PubMed ID: 8914698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking a common sense approach to the chloramine problem.
    Resnick D
    Nephrol News Issues; 1989 Nov; 3(11):49, 51. PubMed ID: 2635895
    [No Abstract]   [Full Text] [Related]  

  • 16. Dialyzer urea and creatinine clearances are not significantly altered in erythropoietin treated maintenance hemodialysis patients.
    Delano BG; Lundin AP; Galonsky R; Quinn-Cefaro RM; Rao TK; Friedman EA
    ASAIO Trans; 1990; 36(1):36-9. PubMed ID: 2306389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An echocardiographic study of the left ventricular functional indices in pediatric patients on hemodialysis and in treatment with recombinant human erythropoietin (r-HuEPO)].
    Seracini D; Pollini I; Lavoratti GC; Pela I; Materassi M; Danti D; De Simone L; Favilli S; Manetti A
    Pediatr Med Chir; 1994; 16(4):389-92. PubMed ID: 7816703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the efficacy and tolerance of recombinant human erythropoietin between intravenous and subcutaneous administration in chronic hemodialysis. Prospective multicenter study].
    Ruedin P; Stoerman C; Pechère-Bertschi A; Leski M
    Nephrologie; 1992; 13(2):87-92. PubMed ID: 1608502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood lead and water treatment.
    Weintraub JM
    Environ Health Perspect; 2007 Oct; 115(10):A487-8; author reply A488-9. PubMed ID: 17938710
    [No Abstract]   [Full Text] [Related]  

  • 20. [Outbreak of hemolytic reactions associated with chlorine and chloramine residuals in hemodialysis water].
    Calderaro RV; Heller L
    Rev Saude Publica; 2001 Oct; 35(5):481-6. PubMed ID: 11723521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.